Intellectual Property: Companies Rush to Patent DNA

See allHide authors and affiliations

Science  07 Feb 1997:
Vol. 275, Issue 5301, pp. 780-781
DOI: 10.1126/science.275.5301.780

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Getting rich on human genes has become a fantasy for many investors in the 1990s. But who ends up rich may have more to do with their skill at navigating patent law—and with the unpredictable decisions of federal judges—than the importance of the biology they have uncovered.